Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 10, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Single-Port Robotic Pulmonary Resection for Non-Small-Cell Lung Cancer After Neoadjuvant Chemoimmunotherapy.

Jun Hee Lee1, Juwhan Choi2, Eun Joo Kang3

  • 1Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul 152-703, Republic of Korea.

European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|May 8, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Dual-Imaging Fluorescent and Iodinated Thermosensitive Hydrogel for Image-Guided Surgery of Pulmonary Nodules.

ACS applied bio materials·2026
Same author

Myositis-Associated Interstitial Lung Disease Presenting as Acute Respiratory Distress Syndrome: A Retrospective Observational Study.

Journal of clinical medicine·2026
Same author

Establishment of a rabbit uterine cancer model using VX2 tumor fragments.

PloS one·2026
Same author

Airway Quantification Using Ultra-Low-Dose Computed Tomography Correlates With Pulmonary Function Indices in Patients With Asthma.

Journal of Korean medical science·2026
Same author

Extended Follow-Up Analysis of First-Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Real-World Multicenter Prospective Cohort Study.

Thoracic cancer·2025
Same author

A comprehensive analysis of antihypertensive medications and their impact on lung cancer incidence and all-cause mortality: a population-based study in South Korea.

Journal of thoracic disease·2025

Single-port robotic pulmonary resection is feasible and safe after neoadjuvant chemoimmunotherapy for non-small-cell lung cancer (NSCLC). Both robotic and VATS approaches offer viable minimally invasive options for selected NSCLC patients.

Area of Science:

  • Thoracic Surgery
  • Surgical Oncology
  • Minimally Invasive Surgery

Background:

  • Neoadjuvant chemoimmunotherapy is increasingly used for non-small-cell lung cancer (NSCLC).
  • Evaluating minimally invasive surgical techniques following neoadjuvant therapy is crucial for optimizing patient outcomes.
  • Single-port (SP) approaches offer potential advantages in reducing surgical trauma.

Purpose of the Study:

  • To assess the feasibility and safety of single-port (SP) robotic pulmonary resection.
  • To compare SP robotic resection with SP video-assisted thoracic surgery (VATS) after neoadjuvant chemoimmunotherapy for NSCLC.
  • To analyze intraoperative and perioperative outcomes between SP robotic and SP VATS groups.

Main Methods:

  • Retrospective review of patients undergoing SP robotic or SP VATS pulmonary resection post-neoadjuvant chemoimmunotherapy.
Keywords:
neoadjuvant immunotherapynon-small-cell lung cancerrobotic thoracic surgerysingle-portsingle-port robotic systemuniportal

More Related Videos

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
04:38

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Published on: April 19, 2024

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
07:27

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

Related Experiment Videos

Last Updated: May 10, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
04:38

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Published on: April 19, 2024

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
07:27

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

  • Comparison of baseline characteristics, operative details, and postoperative outcomes.
  • Analysis included R0 resection rates, conversion rates, operative time, complications, and pain.

    • Main Results:

    • Twenty-four patients were analyzed (10 SP robotic, 14 SP VATS).
    • R0 resection rates were high and comparable (90% SP robotic vs. 93% SP VATS).
    • Perioperative outcomes, including operative time, complications, and pain, were similar between groups, with lower thoracotomy conversion rates in the robotic group.

    Conclusions:

    • Single-port robotic pulmonary resection is technically feasible and safe following neoadjuvant chemoimmunotherapy for NSCLC.
    • SP approaches, including both robotic and VATS, are viable minimally invasive surgical alternatives for selected NSCLC patients.
    • Further research may explore long-term oncological outcomes for these minimally invasive techniques.